Cyclodextrin-Based Niosomal Delivery of Imatinib against A549 Nonsmall Cell Lung Cancer Cells.
- DOI
- 10.1021/acsomega.5c06264
- Published
- 2025 Dec 30
- Container
- ACS omega
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acsomega.5c06264,
title = {Cyclodextrin-Based Niosomal Delivery of Imatinib against A549 Nonsmall Cell Lung Cancer Cells.},
author = {Hnin HM and Tun T and Chansriniyom C and Singharajkomron N and Pongrakhananon V and Loftsson T and Jansook P},
year = {2025},
journal = {ACS omega},
doi = {10.1021/acsomega.5c06264},
url = {https://doi.org/10.1021/acsomega.5c06264}
}RIS
TY - JOUR TI - Cyclodextrin-Based Niosomal Delivery of Imatinib against A549 Nonsmall Cell Lung Cancer Cells. AU - Hnin HM AU - Tun T AU - Chansriniyom C AU - Singharajkomron N AU - Pongrakhananon V AU - Loftsson T AU - Jansook P PY - 2025 JO - ACS omega DO - 10.1021/acsomega.5c06264 UR - https://doi.org/10.1021/acsomega.5c06264 ER -
APA
HM, H., T, T., C, C., N, S., V, P., T, L., & P, J. (2025). Cyclodextrin-Based Niosomal Delivery of Imatinib against A549 Nonsmall Cell Lung Cancer Cells.. ACS omega. https://doi.org/10.1021/acsomega.5c06264
Source records
- pubmed · retrieved 2026-09-25T12:30:02.688Z